Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Emmanuel

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
JAMA Dermatology|December 6, 2023
Efficacy and Safety of the Heat Shock Protein 90 Inhibitor RGRN-305 in Hidradenitis Suppurativa: A Parallel-Design Double-Blind TrialHakim Ben Abdallah, Anne Bregnhøj, Thomas Emmanuel, et al.
Skin Health and Disease|February 6, 2026
Microvascular alterations in nonlesional psoriatic skin versus healthy control skin: insights from optical coherence tomography angiography in psoriasis and atopic dermatitisNina Moustgaard Knudsen, Lars Thrane, Thomas Emmanuel, et al.
Experimental Dermatology|April 4, 2025
Early Neutrophil Activation in Psoriatic Skin at Relapse Following Dead Sea ClimatotherapyThomas Emmanuel, Hakim Ben Abdallah, Elena Baez, et al.
International Journal of Molecular Sciences|February 13, 2026
IL-17 Cytokines Induce IκBζ in Dermal Fibroblasts to Promote Pro-Inflammatory Gene Expression in PsoriasisLejla Svraka, Anna Skarnvad Andersen, Toke Touborg, et al.
Experimental Dermatology|February 23, 2022
Climatotherapy at the Dead Sea for psoriasis is a highly effective anti-inflammatory treatment in the short term: An immunohistochemical studyThomas Emmanuel, Annita Petersen, Hannah Inez Houborg, et al.
Clinical and Experimental Dermatology|April 15, 2024
ERAP1 and ERAP2 gene variants as potential clinical biomarkers of anti-interleukin-17A response in psoriasis vulgarisLasse Kronborg, Emma Oxlund Hansen, Trine Bertelsen, et al.
The Journal of Investigative Dermatology|May 22, 2025
Oral Roflumilast Suppresses Proinflammatory Cytokine Signaling and Reduces CD4+ T-Cell and Neutrophil Infiltration in PsoriasisElena Baez, Mette Gyldenløve, Hakim Ben Abdallah, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 2, 2024
Association of inflammatory skin biomarkers with clinical response in RGRN-305-treated patients with hidradenitis suppurativaHakim Ben Abdallah, Anne Bregnhøj, Thomas Emmanuel, et al.
Frontiers in Oncology|October 22, 2024
RUNX2 as a novel biomarker for early identification of patients progressing to advanced-stage mycosis fungoidesMaria Danielsen, Thomas Emmanuel, Morten Muhlig Nielsen, et al.
International Journal of Molecular Sciences|June 19, 2024
Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease MemoryThomas Emmanuel, Borislav Ignatov, Trine Bertelsen, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
JAMA Dermatology|December 6, 2023
Efficacy and Safety of the Heat Shock Protein 90 Inhibitor RGRN-305 in Hidradenitis Suppurativa: A Parallel-Design Double-Blind TrialHakim Ben Abdallah, Anne Bregnhøj, Thomas Emmanuel, et al.
Skin Health and Disease|February 6, 2026
Microvascular alterations in nonlesional psoriatic skin versus healthy control skin: insights from optical coherence tomography angiography in psoriasis and atopic dermatitisNina Moustgaard Knudsen, Lars Thrane, Thomas Emmanuel, et al.
Experimental Dermatology|April 4, 2025
Early Neutrophil Activation in Psoriatic Skin at Relapse Following Dead Sea ClimatotherapyThomas Emmanuel, Hakim Ben Abdallah, Elena Baez, et al.
International Journal of Molecular Sciences|February 13, 2026
IL-17 Cytokines Induce IκBζ in Dermal Fibroblasts to Promote Pro-Inflammatory Gene Expression in PsoriasisLejla Svraka, Anna Skarnvad Andersen, Toke Touborg, et al.
Experimental Dermatology|February 23, 2022
Climatotherapy at the Dead Sea for psoriasis is a highly effective anti-inflammatory treatment in the short term: An immunohistochemical studyThomas Emmanuel, Annita Petersen, Hannah Inez Houborg, et al.
Clinical and Experimental Dermatology|April 15, 2024
ERAP1 and ERAP2 gene variants as potential clinical biomarkers of anti-interleukin-17A response in psoriasis vulgarisLasse Kronborg, Emma Oxlund Hansen, Trine Bertelsen, et al.
The Journal of Investigative Dermatology|May 22, 2025
Oral Roflumilast Suppresses Proinflammatory Cytokine Signaling and Reduces CD4+ T-Cell and Neutrophil Infiltration in PsoriasisElena Baez, Mette Gyldenløve, Hakim Ben Abdallah, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 2, 2024
Association of inflammatory skin biomarkers with clinical response in RGRN-305-treated patients with hidradenitis suppurativaHakim Ben Abdallah, Anne Bregnhøj, Thomas Emmanuel, et al.
Frontiers in Oncology|October 22, 2024
RUNX2 as a novel biomarker for early identification of patients progressing to advanced-stage mycosis fungoidesMaria Danielsen, Thomas Emmanuel, Morten Muhlig Nielsen, et al.
International Journal of Molecular Sciences|June 19, 2024
Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease MemoryThomas Emmanuel, Borislav Ignatov, Trine Bertelsen, et al.
Pageof 3